Enhanced anticoagulant effect of warfarin in a patient treated with cloxacillin

被引:5
作者
Marusic, Srecko [1 ]
Gojo-Tomic, Nives [1 ]
Bacic-Vrca, Vesna [2 ]
Franic, Miljenko [3 ]
机构
[1] Univ Hosp Dubrava, Dept Clin Pharmacol, Zagreb 10000, Croatia
[2] Univ Hosp Dubrava, Dept Clin Pharm, Zagreb 10000, Croatia
[3] Univ Hosp Dubrava, Dept Orthoped Surg, Zagreb 10000, Croatia
关键词
warfarin; cloxacillin; interaction; coagulopathy; PLASMA-PROTEIN BINDING; HYPOPROTHROMBINEMIC RESPONSE; NAFCILLIN; DICLOXACILLIN; SECONDARY; DRUG;
D O I
10.5414/CP201700
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: To present the case of warfarin-cloxacillin interaction that resulted in an increased international normalized ratio (INR). Case summary: A 70-year-old man had been treated with warfarin for atrial fibrillation. He was hospitalized because of superficial thrombophlebitis of the left median cubital vein, which developed after venipuncture. An antibiotic therapy with cloxacillin was initiated immediately after the admission. Two days later, INR value increased from baseline 1.9 to 4.6. Anticoagulation therapy was discontinued and INR value was measured daily. His INR remained high for the entire duration of antibiotic therapy. Three days after the cloxacillin therapy was discontinued, the INR decreased to the baseline value. Discussion: In the presented case, the temporal relationship between the administration of cloxacillin and increased INR suggests that the cloxacillin was responsible for the enhanced warfarin activity. According to the Drug Interaction Probability Scale, a causal relationship between the warfarin-cloxacillin interaction and increased INR value was rated "probable". Conclusion: Interactions between warfarin and cloxacillin can result in serious adverse reactions. INR value should be closely monitored when patients are prescribed this combination of drugs.
引用
收藏
页码:431 / 433
页数:3
相关论文
共 19 条
[1]   Pharmacology and management of the vitamin K antagonists [J].
Ansell, Jack ;
Hirsh, Jack ;
Hylek, Elaine ;
Jacobson, Alan ;
Crowther, Mark ;
Palareti, Gualtiero .
CHEST, 2008, 133 (06) :160S-198S
[2]   Changes in plasma protein binding have little clinical relevance [J].
Benet, LZ ;
Hoener, BA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (03) :115-121
[3]   BACTERICIDAL ACTIVITY AND PHARMACOLOGY OF FLUCLOXACILLIN [J].
BERGERON, MG ;
BRUSCH, JL ;
BARZA, M ;
WEINSTEIN, L .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1976, 271 (01) :13-20
[4]  
CONLY J, 1994, CLIN INVEST MED, V17, P531
[5]   Decreased INR Response Secondary to Warfarin-Flucloxacillin Interaction [J].
Garg, Alka ;
Mohammed, Mushtaq .
ANNALS OF PHARMACOTHERAPY, 2009, 43 (7-8) :1374-1375
[6]   Systematic overview of warfarin and its drug and food interactions [J].
Holbrook, AM ;
Pereira, JA ;
Labiris, R ;
McDonald, H ;
Douketis, JD ;
Crowther, M ;
Wells, PS .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (10) :1095-1106
[7]   Proposal for a new tool to evaluate drug interaction cases [J].
Horn, John R. ;
Hansten, Philip D. ;
Chan, Lingtak-Neander .
ANNALS OF PHARMACOTHERAPY, 2007, 41 (04) :674-680
[8]  
IBRAHIM OM, 1996, SAUDI PHARM J, V4, P56
[9]   Interaction between warfarin and nafcillin: Case report and review of the literature [J].
Kim, Karissa Y. ;
Frey, R. J. ;
Epplen, Kelly ;
Foruhari, Farzin .
PHARMACOTHERAPY, 2007, 27 (10) :1467-1470
[10]  
KRSTENANSKY PM, 1987, CLIN PHARMACY, V6, P804